NasdaqGM:NTLABiotechs
Is Intellia Therapeutics (NTLA) Pricing Look Interesting After Strong Year-To-Date Share Gain?
If you are wondering whether Intellia Therapeutics is priced attractively today, the key question is how its current share price lines up with the value implied by different valuation methods.
The stock recently closed at US$13.82, with returns of 3.0% over the past week, 5.8% over the last month, 50.1% year to date, and 47.6% over the last year, set against a 65.7% decline over three years and a 76.7% decline over five years.
These moves sit against a backdrop of ongoing attention on gene...